PULM
Pulmatrix (PULM)
$09
About Pulmatrix (PULM)
Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the development and discovery of novel inhaled therapeutics products. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov, and Robert S. Langer, Jr. in April 2003 and is headquartered in Framingham, MA.
Details
Daily high
$2.14
Daily low
$2.05
Price at open
$2.05
52 Week High
$2.75
52 Week Low
$1.55
Market cap
7.6M
Dividend yield
0.00%
Volume
2,555
Avg. volume
11,036
P/E ratio
-.70
Pulmatrix News
Details
Daily high
$2.14
Daily low
$2.05
Price at open
$2.05
52 Week High
$2.75
52 Week Low
$1.55
Market cap
7.6M
Dividend yield
0.00%
Volume
2,555
Avg. volume
11,036
P/E ratio
-.70